Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Rhenman & Partners Asset Management AB decreased its position in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 65.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 112,741 shares of the company’s stock after selling 217,894 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Pliant Therapeutics were worth $2,042,000 […]
Rhenman & Partners Asset Management AB cut its holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 65.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,741 shares of the company’s stock after selling 217,894 shares during the period. Rhenman […]
Several brokerages have updated their recommendations and price targets on shares of Pliant Therapeutics (NASDAQ: PLRX) in the last few weeks: 5/15/2024 – Pliant Therapeutics had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock. 5/7/2024 – Pliant Therapeutics had its price target lowered by […]